Penn Capital Management Company, LLC
Position in LGND — Ligand Pharmaceuticals Inc
CIK 1158202
PHILADELPHIA, PA
Position in LGND
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$31,715,522
+$12,657,732 QoQ
Shares Held
100,337
+5.1% QoQ
Ownership
0.503%
of shares outstanding
% of Portfolio
2.02%
of 13F equity value
Holder Rank
#46
of 413 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Penn Capital Management Company, LLC holds $100,162,194 across 7 Biotechnology names. LGND ranks #2 (31.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
298,914 | $34,993,861 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
This page
|
100,337 | $31,715,522 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
536,067 | $29,451,520 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,811 | $1,509,366 | |
| 5 | TVTX |
Travere Therapeutics, Inc.
|
14,968 | $850,332 | |
| 6 | PVLA |
Palvella Therapeutics, Inc.
|
5,506 | $841,426 | |
| 7 | NRIX |
Nurix Therapeutics, Inc.
|
32,983 | $800,167 |
All Filings in LGND
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,715,522 | 100,337 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $19,057,790 | 95,456 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $18,689,191 | 98,848 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $19,003,933 | 107,282 | Shares | Sole | 2025-11-24 | |
| 2025-06-30 | $13,685,253 | 120,384 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $12,705,012 | 120,839 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $11,189,674 | 104,430 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,030,819 | 100,218 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||